B6J.Cg-Ctnnb1tm3.1Kba/Orl

Status

Available to order

EMMA IDEM:15956
Citation informationRRID:IMSR_EM:15956 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6J.Cg-Ctnnb1tm3.1Kba/Orl
Alternative nameCtnnb1tm3Kba
Strain typeTargeted Mutant Strains : Other targeted
Allele/Transgene symbolCtnnb1tm3.1Kba
Gene/Transgene symbolCtnnb1

Information from provider

ProviderKonrad Basler
Provider affiliationDMLS, University of Zurich
Genetic informationMutation in endogenous locus of b-catenin (catenin beta 1, Ctnnb1). The expressed form of b-catenin is fully functional as a component of adherens junctions, can bind Tcf/Lef transcription factors, but lacks the ability to interact to N- and C-terminal transcriptional co-activators and thus does not transduce Wnt signaling. A point mutation was introduced into exon 4 resulting in a D164A mutation and a floxed hygromycin cassette was inserted via homologous recombination. In a second recombination event, a premature stop codon followed by a frameshift mutation was introduced at amino acid position 673 in exon 13 and this exon was fused to exon 15. The resistance cassette was removed by crossing the mutant allele with flp recombinase deleter strain (post-flp).
Phenotypic informationHomozygous:
Homozygously lethal at gastrulation (before E 7.5).

Heterozygous:
10% of animals show kinky tail.
Breeding historyThe ES cells were from 129 background. After removal of the resistance cassette the strain was crossed with C57BL/6J (in particular: B6JCrl1) for more than 15 generations.
References
  • Probing transcription-specific outputs of β-catenin in vivo.;Valenta Tomas, Gay Max, Steiner Sarah, Draganova Kalina, Zemke Martina, Hoffmans Raymond, Cinelli Paolo, Aguet Michel, Sommer Lukas, Basler Konrad, ;2011;Genes & development;25;2631-43; 22190459
Homozygous fertileno
Homozygous viableno
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France
Animals used for archivingheterozygous C57BL/6J males

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • abnormal bone mineralization / IMPC
  • increased startle reflex / IMPC
  • abnormal cranium morphology / IMPC
  • increased bone mineral density / IMPC
  • abnormal startle reflex / IMPC
  • abnormal head morphology / IMPC
MGI phenotypes (gene matching)
  • growth retardation of molars / MGI
  • increased leukocyte cell number / MGI
  • increased granulocyte number / MGI
  • broad head / MGI
  • abnormal coat/ hair morphology / MGI
  • absent hair follicles / MGI
  • decreased hair follicle number / MGI
  • alopecia / MGI
  • abnormal head morphology / MGI
  • microcephaly / MGI
  • abnormal cranium morphology / MGI
  • domed cranium / MGI
  • flattened snout / MGI
  • gastrointestinal hemorrhage / MGI
  • abnormal small intestine morphology / MGI
  • abnormal foot pad morphology / MGI
  • kinked tail / MGI
  • abnormal sweat gland morphology / MGI
  • tremors / MGI
  • abnormal tongue morphology / MGI
  • decreased corpus callosum size / MGI
  • forebrain hypoplasia / MGI
  • small cerebellum / MGI
  • decreased body size / MGI
  • sparse vibrissae / MGI
  • anophthalmia / MGI
  • microphthalmia / MGI
  • ocular hypertelorism / MGI
  • cataract / MGI
  • dry eyes / MGI
  • impaired coordination / MGI
  • reduced long term potentiation / MGI
  • hunched posture / MGI
  • abnormal coat appearance / MGI
  • impaired balance / MGI
  • abnormal vocalization / MGI
  • abnormal germ layer development / MGI
  • abnormal ectoderm development / MGI
  • abnormal mesoderm development / MGI
  • absent mesoderm / MGI
  • abnormal gastrulation / MGI
  • failure to gastrulate / MGI
  • decreased embryo size / MGI
  • abnormal proximal-distal axis patterning / MGI
  • absent amniotic folds / MGI
  • increased inflammatory response / MGI
  • increased susceptibility to otitis media / MGI
  • conjunctivitis / MGI
  • decreased litter size / MGI
  • deafness / MGI
  • blindness / MGI
  • abnormal hair growth / MGI
  • premature death / MGI
  • abnormal developmental patterning / MGI
  • abnormal extraembryonic tissue morphology / MGI
  • abnormal eye morphology / MGI
  • no abnormal phenotype detected / MGI
  • abnormal cervical lymph node morphology / MGI
  • increased intestinal adenoma incidence / MGI
  • abnormal macrophage physiology / MGI
  • abnormal inner cell mass morphology / MGI
  • small olfactory bulb / MGI
  • abnormal operant conditioning behavior / MGI
  • absent Peyer's patches / MGI
  • increased intestinal adenocarcinoma incidence / MGI
  • no phenotypic analysis / MGI
  • absent allantois / MGI
  • early eyelid opening / MGI
  • abnormal forebrain development / MGI
  • abnormal intestinal goblet cell morphology / MGI
  • abnormal hair follicle development / MGI
  • abnormal embryonic epiblast morphology / MGI
  • increased hepatocyte apoptosis / MGI
  • liver hemorrhage / MGI
  • abnormal craniofacial development / MGI
  • abnormal nitric oxide homeostasis / MGI
  • embryonic growth retardation / MGI
  • abnormal globus pallidus morphology / MGI
  • absent maxilla / MGI
  • abnormal nasal capsule morphology / MGI
  • abnormal synaptic vesicle clustering / MGI
  • short incisors / MGI
  • increased susceptibility to parasitic infection / MGI
  • lethargy / MGI
  • abnormal rostral-caudal axis patterning / MGI
  • increased brain size / MGI
  • narrow eye opening / MGI
  • abnormal corneal stroma morphology / MGI
  • growth retardation of incisors / MGI
  • abnormal corneal epithelium morphology / MGI
  • absent Meibomian glands / MGI
  • small pharyngeal arch / MGI
  • small molars / MGI
  • decreased Peyer's patch number / MGI
  • small Peyer's patches / MGI
  • abnormal spatial reference memory / MGI
  • abnormal peripheral lymph node morphology / MGI
  • absent peripheral lymph nodes / MGI
  • facial cleft / MGI
  • decreased prepulse inhibition / MGI
  • impaired contextual conditioning behavior / MGI
  • small brachial lymph nodes / MGI
  • small axillary lymph nodes / MGI
  • absent popliteal lymph nodes / MGI
  • abnormal hippocampus neuron morphology / MGI
  • abnormal vibrissa follicle morphology / MGI
  • increased gastrointestinal tumor incidence / MGI
  • abnormal mandibular prominence morphology / MGI
  • abnormal maxillary prominence morphology / MGI
  • perinatal lethality, complete penetrance / MGI
  • prenatal lethality, complete penetrance / MGI
  • embryonic lethality, complete penetrance / MGI
  • embryonic lethality between implantation and somite formation, complete penetrance / MGI
  • embryonic lethality during organogenesis, complete penetrance / MGI
  • preweaning lethality, complete penetrance / MGI
  • prenatal lethality, incomplete penetrance / MGI
  • preweaning lethality, incomplete penetrance / MGI
  • increased hair follicle apoptosis / MGI
  • abnormal head size / MGI
  • increased striatum area / MGI
  • Harderian gland atrophy / MGI
  • keratoconjunctivitis sicca / MGI
  • abnormal eyelid margin morphology / MGI
  • enlarged thalamus / MGI
  • abnormal anterior head development / MGI
  • misaligned incisors / MGI

Literature references

  • Probing transcription-specific outputs of β-catenin in vivo.;Valenta Tomas, Gay Max, Steiner Sarah, Draganova Kalina, Zemke Martina, Hoffmans Raymond, Cinelli Paolo, Aguet Michel, Sommer Lukas, Basler Konrad, ;2011;Genes & development;25;2631-43; 22190459

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).